During litigation or contested proceeding the patentee can point to commercial success of a product as evidence of non-obviousness of the claimed product. Although some work is necessary to show the nexus between the success in the market and the claimed invention, the evidence showing, for example, the product taking sales from competitive products could help the patentee's case.

Radio great Paul Harvey would always leave listeners hanging during his broadcast, then return from a commercial with "the rest of the story". Previously, I wrote on the Federal Circuit ruling with respect to Tribal Immunity (https://www.oblon.com/publications/tribal-immunity-in-ipr-is-dealt-a-death-blow-by-the-federal-circuit). At the end of that article I stated: "I note, however, that in the final sentence of their analysis, the Federal Circuit explicitly stated that this decision did NOT address whether there is any reason to treat state sovereign immunity differently with respect to IPR proceedings. That will remain to be seen…"

Stephen McBride wrote an article entitled "Reaching Out" that is featured in the June issue of Intellectual Property Magazine.

Todd Baker and Michael Casey will be attending at this event hosted by Practising Law Institute (PLI) entitled "Advanced Patent Prosecution Workshop 2019: Claim Drafting & Amendment Writing."

Today, Oblon launched its Life Sciences blog, www.lifesciencesipblog.com , which is designed to report and comment on Intellectual property matters related to the life sciences industry.

Oblon was recognized by The Legal 500 as one of the America's leading firms in Patent Prosecution, Re-Examination and Post Grant Proceedings for the 11th straight year.

Oblon celebrated the 10th anniversary of the opening of the Oblon Tokyo Office with a lunch-reception attended by over 60 client guests. Thank you for your support!